The transcription factor PPAR is also a novel target for the treatment of liver disease and synergizes with PGC1α to promote CPT1A expression, which in turn increases fatty acid β‐oxidation; their cooperation plays a key role in fatty acid β‐oxidation (Sun et al., 2018). This evidence concerns the gene PPARGC1A and liver disorder.